Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review.

ABSTRACT: Background/Objectives: Secukinumab was shown to be effective in treating moderate-to-severe plaque psoriasis in adults and pediatric patients ≥6 years. Methods: A literature review was conducted to identify studies published in the preceding 5 years assessing the effectiveness and/or survival (safety in the second instance) associated with secukinumab treatment for moderate-to-severe plaque psoriasis with/without psoriatic arthritis (PsA) in real-world clinical practice in Spain. Results: 11 references were included, corresponding to seven studies (six retrospective and one prospective) (n = 1050). Baseline characteristics were mean age 46.5-53.0 years; 28.7-55.0% women; 30.0-53.1% patients with PsA; 27.9-47.4% naïve to biologic treatments; mean Psoriasis Area and Seve

SUBMITTER: Dauden E 

PROVIDER: S-EPMC11766143 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature